Director's Dealing • Sep 28, 2018
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 3235C
Nuformix PLC
28 September 2018
28 Setember 2018
Nuformix plc
("Nuformix" or the "Company")
PDMR
The Company was notified on 28 September 2018 that Kirk Siderman-Wolter, Non-Executive Director of the Company, bought 35,364 Nuformix plc ordinary shares of 0.1p each ("Shares") at a purchase price of 2.6p per share.
Following this transaction he holds 35,364 shares, representing 0.00077% of the issued share capital of the Company.
| 1 | Details of the person discharging managerial responsibilities. | ||||
| a) | Name | Kirk Siderman-Wolter | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Non-Executive Director | |||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | Nuformix plc | |||
| b) | LEI | 2138003XG3H3I2J3BJ24 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of 0.1p each | |||
| Identification code | GB00BYW79Y38 | ||||
| b) | Nature of the transaction | Acquisition of ordinary Shares | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| 2.6p | 35,364 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume | 35,364 | ||||
| - Price | 2.6p | ||||
| e) | Date of the transaction | 16.08.18 | |||
| f) | Place of the transaction | Standard List, London Stock Exchange |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHPGURUBUPRUBR
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.